ClinicalTrials.Veeva

Menu

Physical Activity in Children at Risk of Post-thrombotic Sequelae (PACT)

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Completed

Conditions

Post Thrombotic Syndrome
Deep Vein Thrombosis

Treatments

Behavioral: 30-minute education session
Device: Fitbit

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT03075761
1K23HL132054-01 (U.S. NIH Grant/Contract)
STU 022016-057

Details and patient eligibility

About

'The PACT trial' is randomized pilot trial to demonstrate the feasibility and potential effectiveness of a personal "fitness tracker" to improve adherence to an activity regimen following an initial acute DVT in children.

Full description

The feasibility of an innovative intervention of a validated fitness tracker, the Fitbit, to improve adherence to a 12-week activity regimen in a pilot randomized controlled trial (RCT) will be tested in 44 subjects with first, acute, proximal lower extremity deep vein thrombosis (DVT).

The primary outcomes will consist of a) feasibility indicators determined a priori (eligibility, consent, adherence, retention) and b) estimates of effect size associated with the prescribed activity regimen, by describing within-subject change in QoL and potential biomarkers of postthrombotic syndrome (PTS) pre and post intervention in each group.

Enrollment

111 patients

Sex

All

Ages

7 to 21 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • A radiologically confirmed, acute, proximal first lower extremity DVT
  • 4 to 8 weeks after starting anticoagulation
  • Out-patient ambulatory status

Exclusion criteria

  • Contraindication to increasing activity such as patients with juvenile arthritis, poor balance, congestive heart failure, etc.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

111 participants in 2 patient groups

Intervention
Experimental group
Description:
Participants randomized to the intervention arm will receive a Fitbit, formal 30-minute education session on post-thrombotic syndrome (PTS) and benefits of increased physical activity. An individualized activity prescription will be provided and participants will be asked to maintain the target level of activity for 12 weeks after determining their habitual activity in the first 4 weeks.
Treatment:
Device: Fitbit
Behavioral: 30-minute education session
Control
Active Comparator group
Description:
Participants randomized to the control arm will receive a formal 30-minute education session on post-thrombotic syndrome (PTS) and the benefits of increased physical activity. Their physical activity will be self-reported in an activity log and by the Gordin activity questionnaire over the 16-week intervention period.
Treatment:
Behavioral: 30-minute education session

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems